Importance of node dissection in relation to neoadjuvant and adjuvant therapy

Area of Science:

• Urology
• Oncology
• Surgical Oncology

Background:

• Multimodal therapy, including chemotherapy, is standard for muscle-invasive bladder cancer.
• Radical cystectomy with pelvic lymphadenectomy is the primary treatment for localized and regionally advanced disease.
• Chemotherapy efficacy in bladder cancer is influenced by surgical quality.

Purpose of the Study:

• To examine the role of pelvic lymph node dissection (PLND) in perioperative chemotherapy for bladder cancer.
• To discuss challenges in standardizing PLND for muscle-invasive bladder cancer.

Main Methods:

• Review of current literature on pelvic lymphadenectomy in bladder cancer treatment.
• Analysis of the impact of lymphadenectomy quality on perioperative chemotherapy outcomes.
• Discussion of existing data limitations and areas for future research.

Main Results:

• Pelvic lymphadenectomy quality significantly impacts chemotherapy effectiveness in bladder cancer.
• The precise boundaries and extent of lymphadenectomy lack definitive evidence (Level I data).
• Variations in pelvic lymph node dissection have undetermined diagnostic and therapeutic consequences.

Conclusions:

• Standardizing pelvic lymphadenectomy is crucial for optimizing perioperative chemotherapy in muscle-invasive bladder cancer.
• Further research is needed to establish clear guidelines for lymphadenectomy extent and technique.
• Defining optimal PLND protocols will improve treatment efficacy and patient management in bladder cancer.